Jennifer L Wilson

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

PLoS computational biology

Experimental biology and medicine (Maywood, N.J.)

CPT: pharmacometrics & systems pharmacology

Integrative biology : quantitative biosciences from nano to macro

Stanford University

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Stanford University Sep 1o 2016 - Aug 31o 2019

United States

Postdoctoral Scholar :: Bioengineering

Education History

Massachusetts Institute of Technology

United States

PHD :: Biological Engineering

Publications

Ellen R Bowen, Phillip DiGiacomo, Hannah P Moeller, Kevin A Guttenplan, Benjamin A H Smith, Marlene L Heberling, Laura Vidano, Nigam Haresh Shah, Mehrdad Shamloo, Jennifer L Wilson, Kevin J Grimes
Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease. Discover mental health 3 (1) (2023)
Jennifer L Wilson, Ethan Steinberg, Rebecca Racz, Russ B Altman, Nigam Shah, Kevin Grimes
A network paradigm predicts drug synergistic effects using downstream protein-protein interactions. CPT: pharmacometrics & systems pharmacology 11 (11) (2022)
Alessio Gravina, Jennifer L Wilson, Davide Bacciu, Kevin J Grimes, Corrado Priami
Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks. PLoS computational biology 18 (5) (2022)
Jennifer L Wilson, Alessio Gravina, Kevin Grimes
From random to predictive: a context-specific interaction framework improves selection of drug protein-protein interactions for unknown drug pathways. Integrative biology : quantitative biosciences from nano to macro 14 (1) (2022)
Jennifer L Wilson, Kit Wun Kathy Cheung, Lawrence Lin, Elizabeth A E Green, Analia I Porrás, Ling Zou, David Mukanga, Paul A Akpa, Delese Mimi Darko, Rae Yuan, Sheng Ding, Wiltshire C N Johnson, Howard A Lee, Emer Cooke, Carl C Peck, Steven E Kern, Dan Hartman, Yoshikazu Hayashi, Peter W Marks, Russ B Altman, Murray M Lumpkin, Kathleen M Giacomini, Terrence F Blaschke
Scientific considerations for global drug development. Science translational medicine 12 (554) (2021)
Jennifer L Wilson, Mike Wong, Nicholas Stepanov, Dragutin Petkovic, Russ Altman
PhenClust, a standalone tool for identifying trends within sets of biological phenotypes using semantic similarity and the Unified Medical Language System metathesaurus. JAMIA open 4 (3) (2021)
Jennifer L Wilson, Dan Lu, Nick Corr, Aaron Fullerton, James Lu
An in vitro quantitative systems pharmacology approach for deconvolving mechanisms of drug-induced, multilineage cytopenias. PLoS computational biology 16 (7) (2020)
Jennifer L Wilson
A scientist engineer's contribution to therapeutic discovery and development. Experimental biology and medicine (Maywood, N.J.) 243 (14) (2018)
Jennifer L Wilson, Rebecca Racz, Tianyun Liu, Oluseyi Adeniyi, Jielin Sun, Anuradha Ramamoorthy, Michael Pacanowski, Russ Altman
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development. PLoS computational biology 14 (12) (2018)
Jennifer L Wilson, Russ B Altman
Biomarkers: Delivering on the expectation of molecularly driven, quantitative health. Experimental biology and medicine (Maywood, N.J.) 243 (3) (2017)

Jennifer L Wilson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jennifer L Wilson